MedTrace Logo

Intranasal Fentanyl for Pain Management

NCT00882960 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2011-05-04

No results posted yet for this study

Summary

Goal of the research will be to demonstrate a reduction in reported pain following the atomization and intra-nasal administration of Fentanyl versus the reduction in pain achieved from intravenous Fentanyl. It is hypothesized that pain should be reduced following fentanyl administration using the intra-nasal atomization equal to the intravenous delivery.

Conditions

Interventions

DRUG

intravenous fentanyl

An IV will be established and used to deliver Fentanyl at 50 micrograms to patients who meet pre-hospital protocol for pain management. Examples of this may be burn patients, fractures, trauma.

DRUG

intra-nasal fentanyl

a mucosal atomization device will be used to deliver 50 mcg of Fentanyl to patients who have been identified at requiring pre-hospital pain management

Sponsors & Collaborators

  • Genesys

    lead OTHER

Principal Investigators

  • Alan R Janssen, D.O. · Director of Emergency Medicine Residency, Genesys Regional Medical Center

  • Ryan P Kirby, M.D. · Resident physician, Genesys Regional Medical Center

  • Stuart Etengoff, D.O. · Core Faculty, Department of Emergency Medicine, Genesys Regional Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00882960 on ClinicalTrials.gov